Attached files
EXHIBIT
32.2
CERTIFICATIONS PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Quarterly Report of MEDITE Cancer
Diagnostics, Inc. (the “Company”) on Form 10-Q for
the quarter ended June 30, 2018, as filed with the Securities
and Exchange Commission on the date hereof (the
“Report”), I, Stephen Von Rump, as Chief Financial
Officer of the Company, certify, pursuant to 18 U.S.C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002, that:
1.
|
The
Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and
|
2.
|
The
information contained in the Report fairly presents, in all
material respects, the financial condition and result of operations
of the Company.
|
|
|
||
By:
|
/s/ Stephen
Von Rump
|
Dated:
|
August
10, 2018
|
|
Stephen
Von Rump
|
|
|
Title:
|
Chief
Financial Officer
(Principal
Financial Officer)
|
This
certification is being furnished to the SEC as an exhibit to the
Report pursuant to Section 906 of the Sarbanes-Oxley Act of
2002 and shall not, except to the extent required by the of the
Sarbanes-Oxley Act of 2002, be deemed filed by the Company for
purposes of Section 18 of the Securities Exchange Act of 1934,
as amended.
A
signed copy of this written statement required by Section 906
of the Sarbanes-Oxley Act of 2002 has been provided by the Company
and will be retained by the Company and furnished to the Securities
and Exchange Commission or its staff upon request.